- Condition: Stroke
Interventions: Other: Treadmill belts of dual-belt treadmill respond to encourage symmetric gait; Other: Treadmill belts of dual-belt treadmill respond to amplify asymmetric gait; Other: No difference in treadmill belt speeds
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Condition: Metastatic Breast Cancer
Interventions: Drug: PLX3397; Drug: Eribulin
Sponsors: University of California, San Francisco; Hope Rugo, MD; Susan G. Komen Breast Cancer Foundation; Plexxikon, Inc.; Eisai Inc.
Not yet recruiting - verified May 2012 - Conditions: WorkStation Intervention; Usual Working Condition
Interventions: Behavioral: WorkStation; Behavioral: Usual Working Condition
Sponsors: Pennington Biomedical Research Center; Pennington Biomedical Research Center; Blue Cross Blue Shield
Recruiting - verified April 2012 - Condition: Methamphetamine Dependence
Intervention: Behavioral: Text messages
Sponsors: New Leaf Treatment Center; New Leaf Treatment Center
Recruiting - verified April 2012 - Conditions: Liver Cancer; Pancreatic Cancer
Interventions: Drug: FOLFOX7 (Folinic acid, 5-Fluorouracil, and Oxaliplatin); Device: TheraSpheres
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Nordion (Canada) Inc.
Recruiting - verified April 2012 - Condition: Methamphetamine Dependence
Interventions: Drug: Atomoxetine; Drug: placebo
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Conditions: Methamphetamine Dependence; Methamphetamine Abuse; Substance Abuse
Interventions: Drug: Placebo; Drug: Varenicline; Drug: Varenicline
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Conditions: Attention Deficit Hyperactivity Disorder; Delayed Circadian Rhythm Disorder
Intervention: Device: Polarized glasses designed to filter out blue light
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified March 2012 - Condition: Methamphetamine Metabolism, CYP2D6 Genotype
Intervention: Drug: A single oral 5 mg of duterium labeled methamphetamine
Sponsors: California Pacific Medical Center Research Institute; California Pacific Medical Center Research Institute; The Children's Mercy Hospital
Not yet recruiting - verified October 2009 - Condition: Disability
Intervention: Behavioral: Aerobic exercise
Sponsors: University of Florida; University of Florida
Not yet recruiting - verified February 2012 - Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung DiseaseConditions: Chronic Lung Disease; Self-efficacy
Intervention:
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified April 2012 - Condition: Hyperopia
Intervention: Procedure: Glasses
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Recruiting - verified April 2012 - Conditions: Depression; Substance Abuse; Substance Use
Intervention: Drug: Creatine monohydrate
Sponsors: University of Utah; Perry Renshaw
Recruiting - verified April 2012 - Condition: Convergence Insufficiency
Interventions: Other: Active home-based computer vergence/accommodative therapy; Procedure: Near target push-ups; Other: Placebo home-based computer vergence/accommodative therapy; Procedure: Placebo yoked prism flippers
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Not yet recruiting - verified January 2012 - Conditions: Postmenopausal Disorder; Blood Pressure; Over Weight
Interventions: Behavioral: Basic Intervention; Behavioral: Enhanced Pedometry; Behavioral: Control Group
Sponsors: Pennington Biomedical Research Center; Pennington Biomedical Research Center; American Heart Association
Recruiting - verified January 2012 - Condition: Hidradenitis Suppurativa
Intervention: Drug: anakinra
Sponsors: University of California, San Francisco; University of California, San Francisco
Not yet recruiting - verified March 2012 - Condition: Diabetic Macular Edema
Intervention: Drug: Macugen (Pegaptanib Sodium)
Sponsors: Retina Institute of Hawaii; Retina Institute of Hawaii; Eyetech Pharmaceuticals
Available - verified December 2011 - Conditions: Age-related Bone Loss; Age Related Muscle Loss; Falls; Fractures
Interventions: Dietary Supplement: potassium bicarbonate; Dietary Supplement: potassium bicarbonate; Other: placebo
Sponsors: Tufts University; Tufts University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified April 2012 - Condition: Chronic Kidney Disease
Interventions: Behavioral: Aerobic exercise training; Behavioral: Health Education
Sponsors: University of Maryland; University of Maryland; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2012 - Condition: Amphetamine-Related Disorders
Interventions: Drug: extended-release naltrexone; Drug: Placebo
Sponsors: National Institute on Drug Abuse (NIDA); National Institute on Drug Abuse (NIDA); Alkermes
Not yet recruiting - verified October 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Amphetamine-dextroamphetamine (AMPH); Drug: Placebo; Behavioral: Well-being therapy
Sponsors: Massachusetts General Hospital; David P. Soskin,M.D.; Harvard University
Recruiting - verified March 2012 - Condition: Post Menopausal
Interventions: Behavioral: videodance; Behavioral: Brisk Walking; Behavioral: delayed entry control
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institute on Aging (NIA)
Recruiting - verified September 2011 - Conditions: Advanced Solid Tumors; Metastatic Breast Cancer; Metastatic Renal Cell Carcinoma
Intervention: Drug: RAD001 + BEZ235
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Peripheral Arterial Disease
Intervention: Behavioral: Supervised exercise Program
Sponsors: Dallas VA Medical Center; American Heart Association
Recruiting - verified September 2011 - Condition: Mechanical Low Back Pain
Interventions: Procedure: Thrust manipulation; Procedure: Non-thrust manipulation
Sponsors: Walsh University; Walsh University
Recruiting - verified September 2011 - Conditions: Traumatic Brain Injury; Walking Impairment; Gait Training
Intervention: Other: Gait Training Method
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC)
Recruiting - verified March 2012 - Condition: Neurofibromatosis Type II
Intervention: Drug: Everolimus (RAD001) , Afinitor®
Sponsors: New York University School of Medicine; New York University School of Medicine; Novartis Pharmaceuticals; The Children's Tumor Foundation
Recruiting - verified January 2012 - Condition: Motor Activity
Interventions: Behavioral: Motor Learning with Visual Feedback; Behavioral: Motor Learning without Visual Feedback; Behavioral: Motor Learning -- Control Group; Behavioral: Somatosensory Learning with Visual Feedback; Behavioral: Somatosensory Learning without Visual Feedback; Behavioral: Control Group - Sensory Task without Learning; Behavioral: Control Group -- no sensory or learning task; Behavioral: Observational Task; Behavioral: Control Group -- Observational Task; Behavioral: Mental Imagery; Behavioral: Control Group - Mental Imagery; Device: Transcranial Direct Current Stimulation
Sponsors: Spaulding Rehabilitation Hospital; Spaulding Rehabilitation Hospital
Recruiting - verified April 2012 - Condition: Methamphetamine Dependence
Intervention: Drug: Doxazosin extended release
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA); Baylor College of Medicine
Recruiting - verified November 2011 - Conditions: Methamphetamine Dependence; Substance Abuse; Methamphetamine Abuse
Interventions: Drug: Varenicline; Drug: Placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified March 2012 - Condition: Photoaging
Interventions: Device: Harvest PRP Separation System; Other: Sterile Saline injection
Sponsors: Northwestern University; Northwestern University
Recruiting - verified June 2011 - Condition: Methamphetamine Dependence
Interventions: Other: placebo; Drug: Naltrexone and Bupropion SR
Sponsors: National Institute on Drug Abuse (NIDA); National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2011 - Condition: Methamphetamine Dependence
Intervention: Drug: Modafinil
Sponsors: California Pacific Medical Center Research Institute; California Pacific Medical Center Research Institute
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Biological: SAR231893 (REGN668); Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified April 2012 - Condition: Postural Tachycardia Syndrome
Interventions: Behavioral: Seated Measurements; Behavioral: Standing Measurements; Behavioral: Self-Administered Surveys
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: Age-Related Macular Degeneration; Retinal Vein Occlusion; Diabetic Macular Edema
Intervention: Drug: pegaptanib sodium injection
Sponsors: Eyetech Pharmaceuticals; Eyetech Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Advanced Solid Malignant Tumors; Advanced Ovarian Cancer
Intervention: Drug: U3-1565
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified March 2012 - Condition: Tuberous Sclerosis Complex
Intervention: Drug: RAD001
Sponsors: Children's Hospital Boston; Mustafa Sahin; Tuberous Sclerosis Alliance; Autism Speaks; Novartis Pharmaceuticals; Seizure Tracker LLC
Recruiting - verified February 2012 - Condition: Solid Tumors
Intervention: Drug: GO-203-2c
Sponsors: Genus Oncology, LLC; Genus Oncology, LLC
Recruiting - verified January 2012 - Conditions: Crystal Methamphetamine Abuse; Crystal Methamphetamine Dependence
Interventions: Behavioral: Behavioral Activation Therapy and Risk Reduction Counseling (BAT-RR); Behavioral: Information, Motivation, Behavioral skills change approach to sexual risk reduction
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Fenway Community Health
Recruiting - verified May 2012 - Condition: Cholangiocarcinoma
Intervention: Device: TheraSphere® Yttrium-90 (Y-90) Microspheres
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Nordion (Canada) Inc.
Recruiting - verified January 2012 - Conditions: HIV; AIDS; Substance Use Disorders
Intervention: Behavioral: Resilient Affective Processing Therapy (RAPT)
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified March 2012 - Condition: Claudication
Interventions: Other: Exercise Training; Other: Normal routine
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; American Heart Association; Joslin Diabetes Center
Recruiting - verified February 2012 - Condition: ADHD
Intervention:
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Recruiting - verified May 2012 - Conditions: Substance-Related Disorders; Dental Caries
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified September 2010 - Condition: Smoking
Intervention: Drug: Donepezil
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified May 2012 - Conditions: Methamphetamine-dependence; Substance Abuse
Interventions: Drug: Ibudilast; Drug: Ibudilast; Drug: Ibudilast
Sponsors: University of California, Los Angeles; University of California, Los Angeles; National Institute on Drug Abuse (NIDA); MediciNova
Recruiting - verified March 2012 - Conditions: Ischemia; Retinal Vein Occlusion; Pathologic Processes; Retinal Diseases; Eye Diseases
Intervention: Drug: ranibizumab
Sponsors: Greater Houston Retina Research; David M. Brown, M.D.; Genentech
Recruiting - verified February 2012 - Condition: Spinal Cord Injury
Intervention: Other: Exercise
Sponsors: University of Miami; University of Miami
Recruiting - verified November 2011 - Conditions: Airway Reflexes, Protective; Recovery After Neuromuscular Block; Anesthetic Recovery
Interventions: Drug: Sevoflurane; Drug: Desflurane
Sponsors: University of California, San Francisco; University of California, San Francisco; Baxter Healthcare Corporation
Recruiting - verified March 2012 - Condition: Non-treatment Seeking Methamphetamine Users
Interventions: Drug: oral placebo and methamphetamine 20mg po; Drug: Prazosin 1mg po and oral methamphetamine placebo; Drug: Prazosin 1mg po and Methamphetamine 20mg po
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Conditions: Adult; Traumatic Brain Injury; fMRI
Interventions: Other: Exercise; Other: Mood Therapy
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC); Center for Neuroscience and Regenerative Medicine (CNRM); Henry Jackson Foundation; Department of Defense
Recruiting - verified April 2012 - Condition: Metastatic Liver Disease
Intervention: Device: TheraSphere, Yttrium-90 glass Microspheres
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center
Recruiting - verified January 2012 - Conditions: Stimulant-Related Disorders; HIV; HIV Infections
Intervention: Drug: Truvada
Sponsors: Friends Research Institute, Inc.; Friends Research Institute, Inc.; University of California, Los Angeles
Recruiting - verified October 2011 - Conditions: Attention Deficit Hyperactivity Disorder; Reading Difficulty or Disability
Interventions: Drug: Methylphenidate; Behavioral: Intensive reading instruction; Behavioral: Parent Training; Drug: Mixed Salt Amphetamine; Drug: Atomoxetine; Drug: Guanfacine
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Dental Caries
Interventions: Device: Fluoride Varnish; Device: Glass Ionomer Sealant
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified March 2012 - Condition: Herpes Zoster
Interventions: Biological: Zoster Vaccine Live; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: HIV Medication Adherence; Methamphetamine Use; Sexual Risk; Poly-substance Use; HIV Infections
Interventions: Behavioral: Motivational Interviewing + Cognitive Behavioral Skills Training; Behavioral: Education Attention Control
Sponsors: Hunter College; Hunter College
Recruiting - verified June 2011 - Conditions: Substance Abuse; HIV Infections
Intervention: Behavioral: Stonewall Project
Sponsors: University of California, San Francisco; University of California, San Francisco; California HIV/AIDS Research Program
Recruiting - verified March 2012 - Condition: Brain Injury
Interventions: Behavioral: Goal-based Self Management; Behavioral: Brain Health Education; Behavioral: Pathfinder Attention Process Training; Behavioral: Brain Health Education with Motor Skills Training (EDU/MOTOR); Behavioral: Tonic and Phasic Alertness Training (TAPAT); Behavioral: Object Discrimination Training (ODT)
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of California, Berkeley
Recruiting - verified March 2012 - Condition: Coronary Artery Disease
Intervention: Device: Diamondback 360 Orbital Atherecotmy System
Sponsors: Cardiovascular Systems Inc; Cardiovascular Systems Inc
Recruiting - verified March 2010 - Conditions: Methamphetamine Dependence; Methamphetamine Abuse; Substance Abuse
Interventions: Drug: Perindopril; Drug: Placebo; Drug: Candesartan
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Condition: Methamphetamine Dependence
Interventions: Drug: methylphenidate; Drug: Methylphenidate
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified January 2010 - Condition: Healthy
Interventions: Procedure: Aspirin ingestion followed by doing a Bleeding Volume Test; Procedure: Gatorade Placebo followed by Bleeding Volume Test.
Sponsors: Klein, Jeffrey A., M.D.; Klein, Jeffrey A., M.D.
Recruiting - verified June 2011 - Condition: Motor Activity
Intervention:
Sponsors: State University of New York - Upstate Medical University; State University of New York - Upstate Medical University
Not yet recruiting - verified November 2009 - Conditions: Leukemia; Acute Lymphocytic Leukemia
Interventions: Drug: Everolimus (RAD001); Drug: Cyclophosphamide; Drug: Vincristine; Drug: Doxorubicin; Drug: Dexamethasone; Drug: Mesna; Drug: Methotrexate; Drug: Ara-C (Cytarabine); Drug: Solu-Medrol; Drug: G-CSF
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Novartis
Recruiting - verified November 2011 - Condition: Liver Cancer
Interventions: Radiation: yttrium Y 90 glass microspheres; Drug: Cisplatin; Drug: Mitomycin; Drug: Doxorubicin
Sponsors: Northwestern University; Northwestern University; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Methamphetamine Dependence
Interventions: Drug: Citicoline; Drug: Placebo
Sponsors: University of Utah; Perry Renshaw; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Conditions: Graves Disease; Hyperthyroidism
Intervention: Drug: Potassium Iodine
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified October 2011 - Condition: Schizophrenia
Interventions: Behavioral: Brain Fitness; Behavioral: Cortex with Insight
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Conditions: Liver Tumors; Hepatocellular Carcinoma; Hepatoma; Neoplasms
Intervention: Device: TheraSphere®
Sponsors: St. Joseph Hospital of Orange; St. Joseph Hospital of Orange
Recruiting - verified March 2012 - Conditions: Acute Myelocytic Leukemia; Acute Lymphocytic Leukemia; Chronic Myelocytic Leukemia; Chronic Lymphocytic Leukemia; Myelodysplastic Syndromes
Intervention: Drug: ON 01910.Na
Sponsors: Onconova Therapeutics, Inc.; Onconova Therapeutics, Inc.
Recruiting - verified January 2012 - Condition: Stroke
Interventions: Other: Surface functional electrical stimulation (FES) assisted movement training; Other: Motor learning; Other: Brain computer interface (BCI) training
Sponsors: Louis Stokes VA Medical Center; National Institute of Neurological Disorders and Stroke (NINDS); Louis Stokes VA Medical Center
Recruiting - verified July 2011 - Condition: Stroke
Interventions: Drug: Sinemet, ritalin, amphetamine, and placebo; Device: Transcranial magnetic stimulation (TMS); Other: Combined drug treatment and TMS
Sponsors: Emory University; Emory University; National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2012 - Conditions: Heroin Dependence; Opioid-Related Disorders; Cocaine Abuse or Dependence
Intervention:
Sponsors: Wayne State University; Wayne State University; National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2011 - Condition: Schizophrenia
Interventions: Behavioral: Neuroadaptive cognitive training; Behavioral: Computer games
Sponsors: University of California, San Francisco; University of California, San Francisco; Stanley Medical Research Institute
Recruiting - verified March 2012 - Condition: Macular Degeneration
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified November 2011 - Condition: Schizophrenia
Interventions: Behavioral: Neuroadaptive cognitive training; Behavioral: Computer games
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Condition: Traumatic Brain Injury
Interventions: Procedure: body weight supported treadmill training; Procedure: traditional physical therapy
Sponsors: The University of Texas, Galveston; The University of Texas, Galveston; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2011 - Conditions: Neurofibromatosis Type 1; Reading Disabilities
Interventions: Behavioral: Tutoring Program I; Behavioral: Tutoring Program II
Sponsors: Vanderbilt University; Vanderbilt University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified June 2011 - Condition: Liver Cancer
Interventions: Radiation: brachytherapy; Radiation: yttrium Y 90 glass microspheres
Sponsors: City of Hope Medical Center; City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Pulmonary Arterial Hypertension; Pulmonary Hypertension; PAH WHO Group I
Interventions: Drug: Sitaxsentan; Drug: Bosentan, Ambrisentan
Sponsors: West Penn Allegheny Health System; West Penn Allegheny Health System; National Institutes of Health (NIH); Baylor College of Medicine; Emory University; University of Chicago; Johns Hopkins University; Tufts Medical Center; Sir Mortimer B. Davis - Jewish General Hospital; London Health Sciences Centre; University of Maryland; University of California, San Francisco; University of Calgary; Chest Medical Associates; Columbia University; Lung Diagnostics, Ltd.; Duke University; University of California, Los Angeles; Latter Day Saints Hospital; Louisiana State University Health Sciences Center in New Orleans; Massachusetts General Hospital; Mayo Clinic; Medical College of Wisconsin; Southeastern Lung Care; Suncoast Lung Center; Children's Hospital Colorad; University Hospitals of Cleveland; University of Colorado, Denver; University of Michigan; University of Pittsburgh; University of Southern California; The University of Texas, Galveston; Vanderbilt University; Wayne State University; Ohio State University; University of Alabama at Birmingham; Washington University School of Medicine; Sentara Norfolk General Hospital; University of Texas Southwestern Medical Center; Bay Area Chest Physicians
Recruiting - verified January 2012 - Condition: Breast Cancer
Intervention: Other: perform dynamic contrast enhanced (DCE) MRI
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Oregon Health and Science University; DeltaPoint,Inc.
Recruiting - verified December 2011 - Conditions: Adult Attention Deficit Hyperactivity Disorder; Cocaine Dependence
Interventions: Drug: Placebo; Drug: Adderall-XR; Drug: Adderall-XR
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2012 - Conditions: Liver Cancer; Metastatic Cancer
Intervention: Radiation: Yttrium Y 90 glass microspheres
Sponsors: Northwestern University; Northwestern University; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Liver Cancer
Intervention: Radiation: yttrium Y 90 glass microspheres
Sponsors: Northwestern University; Northwestern University; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Cataract
Intervention: Device: OCT measurements
Sponsors: Oregon Health and Science University; Oregon Health and Science University; National Eye Institute (NEI)
Recruiting - verified May 2012 - Condition: Cystinosis
Intervention: Drug: Cysteamine
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified November 2011
 |
Amphetamine Clinical Trials |
